PRECIGEN, INC.
For the period ended Dec 31, 2024. Filed Mar 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 19, 2025
PGEN$4.52-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of and
December 31, 2024, and 2023
| (Amounts in thousands, except share data) | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $29,517 | $7,578 |
| Short-term investments | 68,393 | 55,277 |
| Receivables | ||
| Trade, less allowance for credit losses of $0 and $184 as of December 31, 2024 and 2023, respectively. | 926 | 902 |
| Other | 237 | 673 |
| Prepaid expenses and other | 3,341 | 4,325 |
| Total current assets | 102,414 | 68,755 |
| Property, plant and equipment, net | 13,831 | 7,111 |
| Intangible assets, net | 4,455 | 40,701 |
| Goodwill | 19,139 | 26,612 |
| Right-of-use assets | 5,056 | 7,097 |
| Other assets | 371 | 767 |
| Total assets | $145,266 | $151,043 |
December 31, 2024 and 2023
| (Amounts in thousands, except share data) | 2024 | 2023 |
|---|---|---|
| Liabilities, Mezzanine Equity and Shareholders' Equity | ||
| Current liabilities | ||
| Accounts payable | $3,531 | $1,726 |
| Accrued compensation and benefits | 8,417 | 8,250 |
| Other accrued liabilities | 4,812 | 6,223 |
| Indemnification accrual | 3,213 | 5,075 |
| Deferred revenue | 589 | 509 |
| Current portion of lease liabilities | 956 | 1,202 |
| Total current liabilities | 21,518 | 22,985 |
| Deferred revenue, net of current portion | 1,934 | 1,818 |
| Lease liabilities, net of current portion | 4,546 | 5,895 |
| Deferred tax liabilities | — | 1,847 |
| Warrant liabilities | 50,537 | — |
| Total liabilities | 78,535 | 32,545 |
| Commitments and contingencies (Note 15) | ||
| Mezzanine Equity | ||
| Series A Preferred Stock, no par value, 81,000 shares and zero shares authorized as of December 31, 2024 and December 31, 2023, respectively; 79,000 shares and zero shares issued as of December 31, 2024 and December 31, 2023, respectively; aggregate liquidation preference of $79,000 as of December 31, 2024. | 28,218 | — |
| Shareholders' equity | ||
| Common stock, no par value, 400,000,000 shares authorized as of December 31, 2024 and 2023; 292,869,097 shares and 256,398,527 shares issued as of December 31, 2024 and 2023, 107,130,903 shares and 248,919,096 shares outstanding as of December 31, 2024 and 2023, respectively. | — | — |
| Additional paid-in capital | 2,129,207 | 2,084,916 |
| Accumulated deficit | (2,090,706) | (1,964,471) |
| Accumulated other comprehensive income (loss) | 12 | (1,947) |
| Total shareholders' equity | 38,513 | 118,498 |
| Total liabilities, mezzanine equity and shareholders' equity | $145,266 | $151,043 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.